image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 22.71
-4.1 %
$ 2.76 B
Market Cap
206.45
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PRVA stock under the worst case scenario is HIDDEN Compared to the current market price of 22.7 USD, Privia Health Group, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PRVA stock under the base case scenario is HIDDEN Compared to the current market price of 22.7 USD, Privia Health Group, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PRVA stock under the best case scenario is HIDDEN Compared to the current market price of 22.7 USD, Privia Health Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PRVA

image
$26.0$26.0$25.0$25.0$24.0$24.0$23.0$23.0$22.0$22.0$21.0$21.0$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
1.74 B REVENUE
4.74%
17 M OPERATING INCOME
-17.76%
17 M NET INCOME
-26.15%
109 M OPERATING CASH FLOW
35.28%
-12 M INVESTING CASH FLOW
72.13%
4.33 M FINANCING CASH FLOW
16.98%
461 M REVENUE
5.25%
5.25 M OPERATING INCOME
-9.72%
5.37 M NET INCOME
2.70%
74.8 M OPERATING CASH FLOW
125.61%
-6.26 M INVESTING CASH FLOW
-526.50%
619 K FINANCING CASH FLOW
-75.15%
Balance Sheet Privia Health Group, Inc.
image
Current Assets 835 M
Cash & Short-Term Investments 491 M
Receivables 316 M
Other Current Assets 27.5 M
Non-Current Assets 301 M
Long-Term Investments 0
PP&E 6.07 M
Other Non-Current Assets 295 M
43.24 %27.84 %25.96 %Total Assets$1.1b
Current Liabilities 449 M
Accounts Payable 9.76 M
Short-Term Debt 2.55 M
Other Current Liabilities 437 M
Non-Current Liabilities 3.19 M
Long-Term Debt 3.04 M
Other Non-Current Liabilities 153 K
96.57 %Total Liabilities$452.3m
EFFICIENCY
Earnings Waterfall Privia Health Group, Inc.
image
Revenue 1.74 B
Cost Of Revenue 1.56 B
Gross Profit 177 M
Operating Expenses 160 M
Operating Income 17 M
Other Expenses -62 K
Net Income 17 M
2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m002b(2b)177m(160m)17m62k17mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
10.19% GROSS MARGIN
10.19%
0.98% OPERATING MARGIN
0.98%
0.83% NET MARGIN
0.83%
2.26% ROE
2.26%
1.27% ROA
1.27%
1.51% ROIC
1.51%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Privia Health Group, Inc.
image
120m120m100m100m80m80m60m60m40m40m20m20m0020192019202020202021202120222022202320232024202420252025
Net Income 17 M
Depreciation & Amortization 7.27 M
Capital Expenditures 0
Stock-Based Compensation 56.7 M
Change in Working Capital 0
Others 19.5 M
Free Cash Flow 109 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Privia Health Group, Inc.
image
Wall Street analysts predict an average 1-year price target for PRVA of $26.6 , with forecasts ranging from a low of $19 to a high of $40 .
PRVA Lowest Price Target Wall Street Target
19 USD -16.34%
PRVA Average Price Target Wall Street Target
26.6 USD 16.93%
PRVA Highest Price Target Wall Street Target
40 USD 76.13%
Price
Max Price Target
Min Price Target
Average Price Target
404035353030252520201515Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership Privia Health Group, Inc.
image
Sold
0-3 MONTHS
3.61 M USD 3
3-6 MONTHS
0 USD 0
6-9 MONTHS
2.5 M USD 1
9-12 MONTHS
828 K USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
9.31 M USD 2
9-12 MONTHS
7. News
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings growth potential. invezz.com - 1 month ago
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Sameer Patel - Evercore ISI Andrew Mok - Barclays Josh Raskin - Nephron Research Whit Mayo - Leerink Partners Jailendra Singh - Truist Securities A.J. Rice - UBS Jack Slevin - Jeffries Jeff Garro - Stephens Inc Matthew Gillmor - KeyBanc Richard Close - Canaccord Genuity Matt Shea - Needham Ryan Langston - TD Cowen David Larsen - BTIG Adam Ron - Bank of America Michael Ha - Baird Constantine Davides - Citizens JMP Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Tao Qiu - Macquarie Craig Jones - Stifel Operator Thank you for standing by. seekingalpha.com - 2 months ago
Privia Health (PRVA) Lags Q4 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com - 2 months ago
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. globenewswire.com - 2 months ago
Seeking Clues to Privia Health (PRVA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Privia Health (PRVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024. zacks.com - 2 months ago
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. globenewswire.com - 3 months ago
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 3 months ago
DH vs. PRVA: Which Stock Is the Better Value Option? Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 4 months ago
DH vs. PRVA: Which Stock Should Value Investors Buy Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 4 months ago
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 5 months ago
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by. seekingalpha.com - 5 months ago
8. Profile Summary

Privia Health Group, Inc. PRVA

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 2.76 B
Dividend Yield 0.00%
Description Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Contact 950 North Glebe Road, Arlington, VA, 22203 https://www.priviahealth.com
IPO Date April 28, 2021
Employees 1140
Officers Mr. Sarath Degala Chief Operating Officer Mr. Edward Christopher Fargis Esq. Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary Ms. Dana Fields CPA Chief Audit & Compliance Officer Mr. Parth Mehrotra Chief Executive Officer & Director Mr. Robert P. Borchert Senior Vice President of Investor Relations & Corporate Communications Ms. Jenny Harding Chief People Officer Mr. Eric J. Beyer Executive Vice President of Medical Groups Mr. Jay Stevens Senior Vice President & Chief Growth Officer Mr. Chris Voigt Executive Vice President & Chief Technology Officer Mr. David Mountcastle CPA, MBA Executive Vice President, Chief Financial Officer & Principal Accounting Officer